Copernicus Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,089	Closed	-$296K	–	19
2020 Q4	$296K	Sell	3,089 -24,911	-89%	-$2.39M	4.61%	11
2020 Q3	$2.69M	Buy	+28,000	New	+$2.69M	2.56%	13